FDA committee endorses omicron-targeting Covid booster strategy

A key advisory committee to the FDA has voted overwhelmingly in favor of updated Covid-19 vaccines that target the omicron variant, paving the way for manufacturers including Cambridge’s Moderna Inc. to move ahead with their shots.